# MiniMed Group, Inc.: financial statements, quarterly

MMED · Nasdaq · CIK 2062583 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mmed.md) · [Financials](/companies/mmed/financials.md) · [Filings](/companies/mmed/filings.md) · [Insiders](/companies/mmed/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mmed/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-07-26) | period not labelled (2024-10-25) | period not labelled (2025-01-24) | period not labelled (2025-04-25) | period not labelled (2025-07-25) | period not labelled (2025-10-24) | Q3 FY2026 (2026-01-23) | Q4 FY2026 (2026-04-24) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [687](/filings/0001628280-26-025777.md) | [724 d](/filings/0001628280-26-045915.md) | [723](/filings/0001628280-26-060926.md) | not reported | [790](/filings/0001628280-26-025777.md) | [837 d](/filings/0001628280-26-045915.md) | [843](/filings/0001628280-26-060926.md) |
| Cost of revenue | $m | not reported | not reported | [292](/filings/0001628280-26-025777.md) | [318 d](/filings/0001628280-26-045915.md) | [314](/filings/0001628280-26-060926.md) | not reported | [428](/filings/0001628280-26-025777.md) | [357 d](/filings/0001628280-26-045915.md) | [378](/filings/0001628280-26-060926.md) |
| Gross profit | $m | not reported | not reported | [395](/filings/0001628280-26-025777.md) | [405 d](/filings/0001628280-26-045915.md) | [409](/filings/0001628280-26-060926.md) | not reported | [362](/filings/0001628280-26-025777.md) | [480 d](/filings/0001628280-26-045915.md) | [465](/filings/0001628280-26-060926.md) |
| Selling, general and administrative | $m | not reported | not reported | [268](/filings/0001628280-26-025777.md) | [276 d](/filings/0001628280-26-045915.md) | [283](/filings/0001628280-26-060926.md) | not reported | [309](/filings/0001628280-26-025777.md) | [299 d](/filings/0001628280-26-045915.md) | [312](/filings/0001628280-26-060926.md) |
| Operating income | $m | not reported | not reported | [21.0](/filings/0001628280-26-025777.md) | [(148) d](/filings/0001628280-26-045915.md) | [(13.0)](/filings/0001628280-26-060926.md) | not reported | [(100)](/filings/0001628280-26-025777.md) | [(93.0) d](/filings/0001628280-26-045915.md) | [5.0](/filings/0001628280-26-060926.md) |
| Income tax | $m | not reported | not reported | [28.0](/filings/0001628280-26-025777.md) | [21.0 d](/filings/0001628280-26-045915.md) | [3.0](/filings/0001628280-26-060926.md) | not reported | [12.0](/filings/0001628280-26-025777.md) | [93.0 d](/filings/0001628280-26-045915.md) | [4.0](/filings/0001628280-26-060926.md) |
| Net income | $m | [(19.0)](/filings/0001628280-26-025777.md) | [(5.0)](/filings/0001628280-26-025777.md) | [(10.0)](/filings/0001628280-26-025777.md) | [(172) d](/filings/0001628280-26-045915.md) | [(19.0)](/filings/0001628280-26-060926.md) | [(5.0)](/filings/0001628280-26-025777.md) | [(119)](/filings/0001628280-26-025777.md) | [(185) d](/filings/0001628280-26-045915.md) | [0.0](/filings/0001628280-26-060926.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.04)](/filings/0001628280-26-025777.md) | not reported | [(0.08)](/filings/0001628280-26-060926.md) | not reported | [(0.47)](/filings/0001628280-26-025777.md) | not reported | [0.00](/filings/0001628280-26-060926.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.04)](/filings/0001628280-26-025777.md) | not reported | [(0.08)](/filings/0001628280-26-060926.md) | not reported | [(0.47)](/filings/0001628280-26-025777.md) | not reported | [0.00](/filings/0001628280-26-060926.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-04-28) | period not labelled (2024-04-26) | period not labelled (2024-07-26) | period not labelled (2024-10-25) | period not labelled (2025-01-24) | period not labelled (2025-04-25) | period not labelled (2025-07-25) | period not labelled (2025-10-24) | Q3 FY2026 (2026-01-23) | FY2026 (2026-04-24) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [11.0](/filings/0001628280-26-045915.md) | not reported | not reported | [10.0](/filings/0001628280-26-025777.md) | [298](/filings/0001628280-26-060926.md) | [207](/filings/0001628280-26-060926.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [939](/filings/0001628280-26-045915.md) | not reported | not reported | [1,108](/filings/0001628280-26-025777.md) | [1,348](/filings/0001628280-26-060926.md) | [1,417](/filings/0001628280-26-060926.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [4,201](/filings/0001628280-26-045915.md) | not reported | not reported | [4,343](/filings/0001628280-26-025777.md) | [4,630](/filings/0001628280-26-060926.md) | [4,718](/filings/0001628280-26-060926.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [710](/filings/0001628280-26-045915.md) | not reported | not reported | [696](/filings/0001628280-26-025777.md) | [702](/filings/0001628280-26-060926.md) | [782](/filings/0001628280-26-060926.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [871](/filings/0001628280-26-045915.md) | not reported | not reported | [881](/filings/0001628280-26-025777.md) | [1,019](/filings/0001628280-26-060926.md) | [1,098](/filings/0001628280-26-060926.md) |
| Shareholders' equity | $m | [3,402](/filings/0001628280-26-045915.md) | [3,448](/filings/0001628280-26-045915.md) | [3,482](/filings/0001628280-26-025777.md) | [3,462](/filings/0001628280-26-025777.md) | [3,485](/filings/0001628280-26-025777.md) | [3,330](/filings/0001628280-26-060926.md) | [3,537](/filings/0001628280-26-060926.md) | [3,560](/filings/0001628280-26-025777.md) | [3,462](/filings/0001628280-26-025777.md) | [3,611](/filings/0001628280-26-060926.md) | [3,620](/filings/0001628280-26-060926.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-04-25) | period not labelled (2025-07-25) | Q4 FY2026 (2026-04-24) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [83.0 d](/filings/0001628280-26-045915.md) | [(141)](/filings/0001628280-26-060926.md) | [(170) d](/filings/0001628280-26-045915.md) | [(49.0)](/filings/0001628280-26-060926.md) |
| Capital expenditure | $m | [57.0 d](/filings/0001628280-26-045915.md) | [53.0](/filings/0001628280-26-060926.md) | [56.0 d](/filings/0001628280-26-045915.md) | [41.0](/filings/0001628280-26-060926.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-01-24) | period not labelled (2025-07-25) | Q3 FY2026 (2026-01-23) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [253](/filings/0001628280-26-025777.md) | [253](/filings/0001628280-26-060926.md) | [253](/filings/0001628280-26-025777.md) | [281](/filings/0001628280-26-060926.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 281,349,931 at 2026-09-03, from the cover of the [10-Q filed 2026-09-08](/filings/0001628280-26-060926.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.